Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Smolic

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Human Antibodies|December 27, 2021
Mini-review: The market growth of diagnostic and therapeutic monoclonal antibodies - SARS CoV-2 as an exampleYasmine El Abd, Ashraf Tabll, Robert Smolic, et al.
Expert Review of Anti-Infective Therapy|October 5, 2007
Potential role of RNAi in the treatment of HCV infectionMartina Volarevic, Robert Smolic, Catherine H Wu, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|February 28, 2006
Potential applications of siRNA in hepatitis C virus therapyRobert Smolic, Martina Volarevic, Catherine H Wu, et al.
Journal of Clinical and Translational Hepatology|July 12, 2019
HCV Extrahepatic ManifestationsLucija Kuna, Jelena Jakab, Robert Smolic, et al.
Biomedicines|July 8, 2020
Risk Factors Contributing to the Occurrence and Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Patients Treated with Direct-Acting AntiviralsSara Kishta, Ashraf Tabll, Tea Omanovic Kolaric, et al.
Bioconjugate Chemistry|November 1, 2007
A novel G418 conjugate results in targeted selection of genetically protected hepatocytes without bystander toxicityMartina Volarevic, Catherine H Wu, Robert Smolic, et al.
Journal of Clinical Medicine|February 6, 2019
Peptic Ulcer Disease: A Brief Review of Conventional Therapy and Herbal Treatment OptionsLucija Kuna, Jelena Jakab, Robert Smolic, et al.
Medicina (Kaunas, Lithuania)|January 21, 2023
MicroRNAs: Small Molecules with Significant Functions, Particularly in the Context of Viral Hepatitis B and C InfectionFayed Megahed, Ashraf Tabll, Shimaa Atta, et al.
Journal of Clinical and Translational Hepatology|February 19, 2021
An Update on Efficacy and Safety of Emerging Hepatic Antifibrotic AgentsVinka Rupcic Rubin, Kristina Bojanic, Martina Smolic, et al.
Journal of Clinical and Translational Hepatology|September 11, 2015
Update on the Development of Anti-Viral Agents Against Hepatitis CKristin L Macarthur, Robert Smolic, Martina V Smolic, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Human Antibodies|December 27, 2021
Mini-review: The market growth of diagnostic and therapeutic monoclonal antibodies - SARS CoV-2 as an exampleYasmine El Abd, Ashraf Tabll, Robert Smolic, et al.
Expert Review of Anti-Infective Therapy|October 5, 2007
Potential role of RNAi in the treatment of HCV infectionMartina Volarevic, Robert Smolic, Catherine H Wu, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|February 28, 2006
Potential applications of siRNA in hepatitis C virus therapyRobert Smolic, Martina Volarevic, Catherine H Wu, et al.
Journal of Clinical and Translational Hepatology|July 12, 2019
HCV Extrahepatic ManifestationsLucija Kuna, Jelena Jakab, Robert Smolic, et al.
Biomedicines|July 8, 2020
Risk Factors Contributing to the Occurrence and Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Patients Treated with Direct-Acting AntiviralsSara Kishta, Ashraf Tabll, Tea Omanovic Kolaric, et al.
Bioconjugate Chemistry|November 1, 2007
A novel G418 conjugate results in targeted selection of genetically protected hepatocytes without bystander toxicityMartina Volarevic, Catherine H Wu, Robert Smolic, et al.
Journal of Clinical Medicine|February 6, 2019
Peptic Ulcer Disease: A Brief Review of Conventional Therapy and Herbal Treatment OptionsLucija Kuna, Jelena Jakab, Robert Smolic, et al.
Medicina (Kaunas, Lithuania)|January 21, 2023
MicroRNAs: Small Molecules with Significant Functions, Particularly in the Context of Viral Hepatitis B and C InfectionFayed Megahed, Ashraf Tabll, Shimaa Atta, et al.
Journal of Clinical and Translational Hepatology|February 19, 2021
An Update on Efficacy and Safety of Emerging Hepatic Antifibrotic AgentsVinka Rupcic Rubin, Kristina Bojanic, Martina Smolic, et al.
Journal of Clinical and Translational Hepatology|September 11, 2015
Update on the Development of Anti-Viral Agents Against Hepatitis CKristin L Macarthur, Robert Smolic, Martina V Smolic, et al.
Pageof 4